Actinic Keratosis (Hornlike Projection Known As Cutaneous Horn)

Total Page:16

File Type:pdf, Size:1020Kb

Actinic Keratosis (Hornlike Projection Known As Cutaneous Horn) ACTINIC KERATOSES DEFINITION Actinic keratoses (also known as solar keratosis) are rough, scaly erythematous patches or spots on the skin that develop on sun-damaged skin typically in elderly patients with lighter skin types from years of exposure to the sun. They are most commonly found on areas of skin typically exposed to the sun ( face, lips, ears, back of the hands, forearms, scalp or neck). Actinic keratoses enlarge slowly, take years to develop (usually first appearing in older adults) and usually cause no signs or symptoms other than the lesion on the skin. OVERVIEW Actinic keratoses (Ak) (also called "solar keratoses" and "senile keratoses") represent focal areas of abnormal keratinocyte proliferation and are considered premalignant lesions with low individual potential to malignant transformation (less than 1 in 1000 per annum) (pregression to squamous cell carcinoma - SCC) and a high spontaneous regression (in the order of 15-25% for Aks over 1-year period) Aks are often recognized by touch rather than sight. In fact Aks start out as small barely perceivable rough spots of skin that feel similar to rubbing sandpaper. The color ranges from skin-colored to pink to reddish brown. Most often, they appear as multiple discrete, flat or elevated, thickened, scaly or warty, keratotic lesions. Lesions typically have an erythematous base . They are usually 3-10 mm in diameter and grow slowly, usually without signs or symptoms but occasionally they may become pruritic or tender. They may enlarge into broader, more elevated hyperkeratotic plaques several centimetres in diameter. Occasionally, a lesion grows to resemble an animal horn and is called a “cutaneous horn (often referred has hypertrophic AK). Development of AKs may occur as early as the third or fourth decade of life in individuals who live in areas of high solar radiation, are fair-skinned with a history of extensive sun exposure, and do not use sunscreen for photoprotection. Usually, patients demonstrate a background of solar-damaged skin with telangiectasias, elastosis, and pigmented lentigines. 1 WHAT DOES AK MEAN? The two words “actinic” and “keratoses” precisely describe what has happened to the skin. “Actinic” comes from the Greek word for ray, “aktis,” and indicates that radiant energy (such as sunlight) has produced chemical changes. The word “keratoses” means the skin has become hard and callous. So AK literally means thickened scaly growth (keratosis) caused by sunlight (actinic). 2 WHAT DOES AK LOOK LIKE? While AKs, usually multiple, share common characteristics, such as being flat to slightly raised or thickened, dry or crusty, scaly or warty, rough patch or bump on sun-damaged skin. But not all AKs look alike. Some are skin-colored and may be easier to feel than see. These lesions often feel much like sandpaper. The base color may be light or dark, ranging from pink to red to brown, or a combination of these or the same color as skin. Each one can range from the size of a pinhead to 2-3 cm across. The top of each one may have a yellow-white crust. They feel rough and dry, and are slightly raised from the surface of the skin. Several solar keratoses may develop at about the same time, often in the same area of skin. Sometimes several join together and form a large flatish rough area of skin. Solar keratoses usually develop on areas of skin which have been exposed to the sun a lot. For example, on the face, neck, bald patches on the scalp, and the backs of the hands. They may appear in other areas in people who do a lot of sunbathing. There are usually no other symptoms. Rarely, may get an itchy, pricking or tender sensation from affected areas of skin. It can also become inflamed and surrounded by redness. In rare instances, actinic keratoses can bleed. Aks later grow into a tough, wart-like area. Sometimes AKs undergo rapid upward growth producing an exaggerated hyperkeratosis: a finger-like growth of hard skin, a horn-like projection above the skin surface appears to come out of a solar keratosis : it becomes a “cutaneous horn,” so named because it resembles the horn of an animal. The size of a cutaneous horn may range from that of a 3 pinhead to a pencil eraser, and the shape may be straight or curved. Sometimes skin cancer hides below a cutaneous horn. The skin around an AK tends to show evidence of sun damage, such as wrinkles and furrows (deep wrinkles). Clinically AK can be divided in three grades: • Grade I - easy visible, slightly palpable (feels better than seen) • Grade II - easily visible, palpable (easily felt and seen) • Grade III - frankly visible, hyperkeratotic (clinically obvious) The lesions begin as small, rough spots that are easier felt than seen with a sandpaperlike texture . With time, the lesions enlarge, usually becoming red and scaly. Most lesions are only 3-10 mm, but they may enlarge to several centimeters in size. Actinic keratoses may show the following variants: • Hyperkeratotic actinic keratosis (hornlike projection known as cutaneous horn) • Bowenoid actinic keratosis 4 • Pigmented actinic keratosis (also known as spreading pigmented AK, displays a variable color, ranging from brown to yellowish-black, with a smooth, verrucous or slightly scaly surface) 5 • Lichenoid (lichen planus-like) actinic keratosis (a pink papule or plaque, frequently located on the upper extremities and upper torso, and may be difficult to differentiate clinically from BCC). • Atrophic actinic keratosis (lacks the epidermal proliferation seen in the hypertrophic type) 6 Overlapping between subtypes may be observed. WHO GETS ACTINIC KERATOSES? Because long-term UV light exposure is implicated as the cause of Aks and AKs frequency correlates with cumulative UV exposure, AKs are more common in patients aged 50 years and older. The typical patient with AKs is an elderly, fair-skinned, sun-sensitive person. AKs occur almost exclusively in whites, especially those fair skin, redheaded or blond with blue, green or hazel eyes, who burn frequently and tan poorly. Because their skin has less protective pigment, they are the most susceptible to sunburn and other forms of sun damage. According with Fitzpatrick skin type, patients with AKs tend to have Fitzpatrick type I or II skin, which burns and does not tan. The prevalence is reduced in persons with Fitzpatrick types III, IV, and V skin and is nonexistent in those with Fitzpatrick type VI skin. Sensitivity to UV light is inherited. The incidence increases with each decade of life and is greater in residents of sunny countries closer to the equator. Men have a slightly increased frequency of AK. But AKs also affect individuals with a history of cumulative sun exposure, who have had increased sun exposure and higher-intensity exposure such as having worked outdoors for long periods or who work with substances that contain polycyclic aromatic hydrocarbons such as coal or tar. For exemple roofers that work with tar and outdoors. Sun-damaged skin is also dry, discoloured and wrinkled. Patients immunosuppressed following organ transplantation are at markedly increased risk of developing AKs just like people affected by albinism or xeroderma pigmentosum, whose skin is very sensitive to UV rays. 7 WHEN DOES AK APPEAR? As it usually takes years of sun exposure to develop an AK (because directly correlated to cumulative UV exposure), older people tend to be the most commonly affected. So likelihood of developing Ks increases with age, and lesions usually appears after age 50. But Aks may appear at a much earlier age in people who live in geographic areas with year-round high-intensity sunlight, who work outdoors, or who do a lot of sunbathing or use tanning beds and sun lamps. Development of actinic keratoses may occur as early as the third or fourth decade of life in patients who live in areas of high solar radiation, are fair-skinned, and do not use sunscreen for photoprotection. Summarizing, frequency increases with skin type, age (50 years and older), proximity to the equator, outdoor occupation, amount of sun damage. 8 WHY DOES AK APPEAR? Ak is a reflection of abnormal skin cell development due to exposure to chronic exposure to ultraviolet light (both UVB -290-320 nm and UVA -320-400 nm). While UV-A (320 - 400 nm) induced photo-oxidative stress indirectly induces characteristic DNA mutations, UV-B (290 - 320 nm) irradiation directly results in the formation of cyclobutane (thymin) dimer formation in DNA and RNA. If there are no appropriate repair mechanisms, these DNA changes are the starting phase of keratinocyte mutations which can progress into the development of AKs. UV radiations are not only the initiators but also the promoters. Other factors that can induce AKS are repeated iatrogenic exposure to UV-A, with or without combination with psoralenes, X-rays or radioisotopes. The skin is normally pretty good at repairing any minor damage. Indeed overexposure to UV in normal skin induces an intrinsic, highly complex programme of auto-orchestrated cell death (p53-dependent apoptosis), which serves to protect the skin from damaged cells. Histologically these individual apoptotic keratinocytes are often seen in the epidermis of skin overexposed to sunlight or UV radiation and are known as "sunburn" cells. But, over the years, some areas of skin are unable to cope with the repeated exposure to sun: UVs induce mutations of the tumor suppressor gene TP53 and basal keratinocytes with mutated TP53 may not respond normally to UV-induced apoptosis, allowing further proliferation and development of new genetic abnormalities. 9 Immunosuppression following solid organ transplantation may increase the risk for aktinic keratosis, but, only if there is sun exposure. So, it is not a recent bout of sun-tanning that causes them but repeated minor sun- damage to the skin over time: AK frequency correlates with cumulative UV exposure.
Recommended publications
  • Glossary for Narrative Writing
    Periodontal Assessment and Treatment Planning Gingival description Color: o pink o erythematous o cyanotic o racial pigmentation o metallic pigmentation o uniformity Contour: o recession o clefts o enlarged papillae o cratered papillae o blunted papillae o highly rolled o bulbous o knife-edged o scalloped o stippled Consistency: o firm o edematous o hyperplastic o fibrotic Band of gingiva: o amount o quality o location o treatability Bleeding tendency: o sulcus base, lining o gingival margins Suppuration Sinus tract formation Pocket depths Pseudopockets Frena Pain Other pathology Dental Description Defective restorations: o overhangs o open contacts o poor contours Fractured cusps 1 ww.links2success.biz [email protected] 914-303-6464 Caries Deposits: o Type . plaque . calculus . stain . matera alba o Location . supragingival . subgingival o Severity . mild . moderate . severe Wear facets Percussion sensitivity Tooth vitality Attrition, erosion, abrasion Occlusal plane level Occlusion findings Furcations Mobility Fremitus Radiographic findings Film dates Crown:root ratio Amount of bone loss o horizontal; vertical o localized; generalized Root length and shape Overhangs Bulbous crowns Fenestrations Dehiscences Tooth resorption Retained root tips Impacted teeth Root proximities Tilted teeth Radiolucencies/opacities Etiologic factors Local: o plaque o calculus o overhangs 2 ww.links2success.biz [email protected] 914-303-6464 o orthodontic apparatus o open margins o open contacts o improper
    [Show full text]
  • Skin Lesions in Diabetic Patients
    Rev Saúde Pública 2005;39(4) 1 www.fsp.usp.br/rsp Skin lesions in diabetic patients N T Foss, D P Polon, M H Takada, M C Foss-Freitas and M C Foss Departamento de Clínica Médica. Faculdade de Medicina de Ribeirão Preto. Universidade de São Paulo. Ribeirão Preto, SP, Brasil Keywords Abstract Skin diseases. Dermatomycoses. Diabetes mellitus. Metabolic control. Objective It is yet unknown the relationship between diabetes and determinants or triggering factors of skin lesions in diabetic patients. The purpose of the present study was to investigate the presence of unreported skin lesions in diabetic patients and their relationship with metabolic control of diabetes. Methods A total of 403 diabetic patients, 31% type 1 and 69% type 2, underwent dermatological examination in an outpatient clinic of a university hospital. The endocrine-metabolic evaluation was carried out by an endocrinologist followed by the dermatological evaluation by a dermatologist. The metabolic control of 136 patients was evaluated using glycated hemoglobin. Results High number of dermophytosis (82.6%) followed by different types of skin lesions such as acne and actinic degeneration (66.7%), pyoderma (5%), cutaneous tumors (3%) and necrobiosis lipoidic (1%) were found. Among the most common skin lesions in diabetic patients, confirmed by histopathology, there were seen necrobiosis lipoidic (2 cases, 0.4%), diabetic dermopathy (5 cases, 1.2%) and foot ulcerations (3 cases, 0.7%). Glycated hemoglobin was 7.2% in both type 1 and 2 patients with adequate metabolic control and 11.9% and 12.7% in type 1 and 2 diabetic patients, respectively, with inadequate metabolic controls.
    [Show full text]
  • Arsenicosis Presenting with Cutaneous Squamous Cell Carcinoma: a Case Report
    CASE REPORT Arsenicosis Presenting with Cutaneous Squamous Cell Carcinoma: A Case Report Marie Len A. Camaclang,1 Eileen Liesl A. Cubillan2 and Claudine Yap-Silva2 1Section of Dermatology, Department of Medicine, Philippine General Hospital, University of the Philippines Manila 2Section of Dermatology, Department of Medicine, College of Medicine and Philippine General Hospital, University of the Philippines Manila ABSTRACT A 29-year-old male with eleven-year history of hyperkeratotic papules and speckled pigmentation developed cutaneous squamous cell carcinoma. Arsenicosis was confirmed by elevated hair arsenic level, and histopathologic findings of arsenical keratosis and one lesion showing carcinoma-in-situ. Chronic arsenic exposure has been found to activate inflammatory and carcinogenic pathways leading to development of pre-malignant and malignant lesions. A multi-disciplinary approach involving healthcare specialists and environmentalists is crucial in source control and management of long-term complications. Key Words: arsenic, arsenic poisoning, arsenicosis, skin cancer, squamous cell carcinoma INTRODUCTION Arsenic is a potential human carcinogen of public health concern. Exposure may be via inhalation of arsenic dusts, direct contact with arsenites, or ingestion of contaminated water, the latter being the most common route.1 Chemical contamination of groundwater may come from natural sources such as geochemical processes (e.g. volcanic activities), as well as the result of human activities including mining wastes, landfills,
    [Show full text]
  • The Management of Common Skin Conditions in General Practice
    Management of Common Skin Conditions In General Practice including the “red rash made easy” © Arroll, Fishman & Oakley, Department of General Practice and Primary Health Care University of Auckland, Tamaki Campus Reviewed by Hon A/Prof Amanda Oakley - 2019 http://www.dermnetnz.org Management of Common Skin Conditions In General Practice Contents Page Derm Map 3 Classic location: infants & children 4 Classic location: adults 5 Dermatology terminology 6 Common red rashes 7 Other common skin conditions 12 Common viral infections 14 Common bacterial infections 16 Common fungal infections 17 Arthropods 19 Eczema/dermatitis 20 Benign skin lesions 23 Skin cancers 26 Emergency dermatology 28 Clinical diagnosis of melanoma 31 Principles of diagnosis and treatment 32 Principles of treatment of eczema 33 Treatment sequence for psoriasis 34 Topical corticosteroids 35 Combination topical steroid + antimicrobial 36 Safety with topical corticosteroids 36 Emollients 37 Antipruritics 38 For further information, refer to: http://www.dermnetnz.org And http://www.derm-master.com 2 © Arroll, Fishman & Oakley, Department of General Practice and Primary Health Care, University of Auckland, Tamaki Campus. Management of Common Skin Conditions In General Practice DERM MAP Start Is the patient sick ? Yes Rash could be an infection or a drug eruption? No Insect Bites – Crop of grouped papules with a central blister or scab. Is the patient in pain or the rash Yes Infection: cellulitis / erysipelas, impetigo, boil is swelling, oozing or crusting? / folliculitis, herpes simplex / zoster. Urticaria – Smooth skin surface with weals that evolve in minutes to hours. No Is the rash in a classic location? Yes See our classic location chart .
    [Show full text]
  • In Dermatology Visit with Me to Discuss
    From time to time new treatments surface for any medical field, and the last couple of years have seen new treatments emerge, or new applications for familiar treatments. I wanted to summarize some of these New Therapies widely available remedies and encourage you to schedule a in Dermatology visit with me to discuss. Written by Board Certified Dermatologist James W. Young, DO, FAOCD Nicotinamide a significant reduction in melanoma in Antioxidants Nicotinamide (niacinamide) is a form high risk skin cancer patients at doses Green tea, pomegranate, delphinidin of vitamin B3. The deficiency of vitamin more than 600 and less than 4,000 IU and fisetin are all under current study for daily. B3 causes pellagra, a condition marked either oral or topical use in the reduction by 4D’s – (photo) Dermatitis, Dementia, Polypodium Leucotomos of the incidence of skin cancer, psoriasis Diarrhea and (if left untreated) Death. and other inflammatory disorders. I’ll be Polypodium leucotomos is a Central This deficiency is rare in developed sure to keep patients updated. countries, but is occasionally seen America fern that is available in several in alcoholism, dieting restrictions, or forms, most widely as Fernblock What Are My Own Thoughts? malabsorption syndromes. Nicotinamide (Amazon) or Heliocare (Walgreen’s and I take Vitamin D 1,000 IU and Heliocare does not cause the adverse effects of Amazon) and others. It is an antioxidant personally. Based on new research, I Nicotinic acid and is safe at doses up to that reduces free oxygen radicals and have also added Nicotinamide which 3,000mg daily. may reduce inflammation in eczema, dementia, sunburn, psoriasis, and vitiligo.
    [Show full text]
  • What Is Acne? Acne Is a Disease of the Skin's Sebaceous Glands
    What is Acne? Acne is a disease of the skin’s sebaceous glands. Sebaceous glands produce oils that carry dead skin cells to the surface of the skin through follicles. When a follicle becomes clogged, the gland becomes inflamed and infected, producing a pimple. Who Gets Acne? Acne is the most common skin disease. It is most prevalent in teenagers and young adults. However, some people in their forties and fifties still get acne. What Causes Acne? There are many factors that play a role in the development of acne. Some of these include hormones, heredity, oil based cosmetics, topical steroids, and oral medications (corticosteroids, lithium, iodides, some antiepileptics). Some endocrine disorders may also predispose patients to developing acne. Skin Care Tips: Clean skin gently using a mild cleanser at least twice a day and after exercising. Scrubbing the skin can aggravate acne, making it worse. Try not to touch your skin. Squeezing or picking pimples can cause scars. Males should shave gently and infrequently if possible. Soften your beard with soap and water before putting on shaving cream. Avoid the sun. Some acne treatments will cause skin to sunburn more easily. Choose oil free makeup that is “noncomedogenic” which means that it will not clog pores. Shampoo your hair daily especially if oily. Keep hair off your face. What Makes Acne Worse? The hormone changes in females that occur 2 to 7 days prior to period starting each month. Bike helmets, backpacks, or tight collars putting pressure on acne prone skin Pollution and high humidity Squeezing or picking at pimples Scrubs containing apricot seeds.
    [Show full text]
  • The Risk of Cancer in Patients with Psoriasis a Population-Based Cohort Study in the Health Improvement Network
    Research Original Investigation The Risk of Cancer in Patients With Psoriasis A Population-Based Cohort Study in the Health Improvement Network Zelma C. Chiesa Fuxench, MD; Daniel B. Shin, MS; Alexis Ogdie Beatty, MD, MSCE; Joel M. Gelfand, MD, MSCE IMPORTANCE The risk of cancer in patients with psoriasis remains a cause of special concern due to the chronic inflammatory nature of the disease, the use of immune-suppressive treatments and UV therapies, and the increased prevalence of comorbid, well-established risk factors for cancer, such as smoking and obesity, all of which may increase the risk of carcinogenesis. OBJECTIVE To compare the overall risk of cancer, and specific cancers of interest, in patients with psoriasis compared with patients without psoriasis. DESIGN, SETTING, AND PARTICIPANTS Population-based cohort study of patients ages 18 to 89 years with no medical history of human immunodeficiency virus, cancer, organ transplants, or hereditary disease (albinism and xeroderma pigmentosum), prior to the start date, conducted using The Health Improvement Network, a primary care medical records database in the United Kingdom. The data analyzed had been collected prospectively from 2002 through January 2014. The analysis was completed in August 2015. EXPOSURES OF INTEREST Patients with at least 1 diagnostic code for psoriasis were classified as having moderate-to-severe disease if they had been prescribed psoralen, methotrexate, cyclosporine, acitretin, adalimumab, etanercept, infliximab, or ustekinumab or phototherapy for psoriasis. Patients were classified as having mild disease if they never received treatment with any of these agents. MAIN OUTCOMES AND MEASURES Incident cancer diagnosis. RESULTS A total of 937 716 control group patients without psoriasis, matched on date and practice visit, and 198 366 patients with psoriasis (186 076 with mild psoriasis and 12 290 with moderate-to-severe disease) were included in the analysis.
    [Show full text]
  • Topical Treatments for Seborrheic Keratosis: a Systematic Review
    SYSTEMATIC REVIEW AND META-ANALYSIS Topical Treatments for Seborrheic Keratosis: A Systematic Review Ma. Celina Cephyr C. Gonzalez, Veronica Marie E. Ramos and Cynthia P. Ciriaco-Tan Department of Dermatology, College of Medicine and Philippine General Hospital, University of the Philippines Manila ABSTRACT Background. Seborrheic keratosis is a benign skin tumor removed through electrodessication, cryotherapy, or surgery. Alternative options may be beneficial to patients with contraindications to standard treatment, or those who prefer a non-invasive approach. Objectives. To determine the effectiveness and safety of topical medications on seborrheic keratosis in the clearance of lesions, compared to placebo or standard therapy. Methods. Studies involving seborrheic keratosis treated with any topical medication, compared to cryotherapy, electrodessication or placebo were obtained from MEDLINE, HERDIN, and Cochrane electronic databases from 1990 to June 2018. Results. The search strategy yielded sixty articles. Nine publications (two randomized controlled trials, two non- randomized controlled trials, three cohort studies, two case reports) covering twelve medications (hydrogen peroxide, tacalcitol, calcipotriol, maxacalcitol, ammonium lactate, tazarotene, imiquimod, trichloroacetic acid, urea, nitric-zinc oxide, potassium dobesilate, 5-fluorouracil) were identified. The analysis showed that hydrogen peroxide 40% presented the highest level of evidence and was significantly more effective in the clearance of lesions compared to placebo. Conclusion. Most of the treatments reviewed resulted in good to excellent lesion clearance, with a few well- tolerated minor adverse events. Topical therapy is a viable option; however, the level of evidence is low. Standard invasive therapy remains to be the more acceptable modality. Key Words: seborrheic keratosis, topical, systematic review INTRODUCTION Description of the condition Seborrheic keratoses (SK) are very common benign tumors of the hair-bearing skin, typically seen in the elderly population.
    [Show full text]
  • What Is Acne and Why Do I Have Pimples?
    What is acne and why do I have pimples? The medical term for “pimples” is acne. Most people develop at least some acne, especially during their teenage years. Although many believe that acne comes from being dirty, this is not true; rather, acne is the result of changes that occur during puberty. Your skin is made of layers. To keep the skin from getting dry, the skin makes oil in little wells called “sebaceous glands” that are found in the deeper layers of the skin. “Whiteheads” or “blackheads” are clogged sebaceous glands. “Blackheads” are not caused by dirt blocking the pores, but rather by oxidation (a chemical reaction that occurs when the oil reacts with oxygen in the air). People with acne have glands that make more oil and are more easily plugged, causing the glands to swell. Hormones, bacteria (called P. acnes) and your family’s likelihood to have acne (genetic susceptibility) also play a role. SKIN HYGIENE Good skin care habits are important and support the medications your doctor prescribes for your acne. » Wash your face twice a day, once in the morning and once in the evening (which includes any showers you take). » Avoid over-washing/over-scrubbing your face as this will not improve the acne and may lead to dryness and irritation, which can interfere with your medications. » In general, milder soaps and cleansers are better for acne-prone skin. The soaps labeled “for sensitive skin” are milder than those labeled “deodorant soap” or “antibacterial soap.” » Many “acne washes” may contain salicylic acid. Salicylic acid (SA) fights oil and bacteria mildly but can be drying and can add to irritation.
    [Show full text]
  • Actinic Keratoses Final Report
    Actinic Keratoses Final Report Mark Helfand, MD, MPH Annalisa K. Gorman, MD Susan Mahon, MPH Benjamin K.S. Chan, MS Neil Swanson, MD Submitted to the Agency for Healthcare Research and Quality under contract 290-97-0018, task order no. 6 Oregon Health & Science University Evidence-based Practice Center 3181 SW Sam Jackson Park Road Portland, Oregon 97201 May 19, 2001 Actinic Keratoses Structured Abstract Objective: To examine evidence about the natural history and management of actinic keratoses (AKs). Search Strategy: We searched the MEDLINE database from January 1966 to January 2001, the Cochrane Controlled Trials Registry, and a bibliographic database of articles about skin cancer. We identified additional articles from reference lists and experts. Selection Criteria: We selected 45 articles that contained original data relevant to treatment of actinic keratoses, progression of AKs to squamous cell cancer (SCC ), means of identifying a high-risk group, or surveillance of patients with AKs to detect and treat SCCs early in their course. Data Collection and Analysis: We abstracted information from these studies to construct evidence tables. We also developed a simple mathematical model to examine whether estimates of the rate of progression of AK to SCC were consistent among studies. Finally, we analyzed data from the Medicare Statistical System to estimate the frequency of procedures attributable to AK among elderly beneficiaries. Main Results: The yearly rate of progression of an AK in an average-risk person in Australia is between 8 and 24 per 10,000. High-risk individuals with multiple AKs have progression rates as high as 12-30 percent over 3 years.
    [Show full text]
  • Advanced Technology with Maximum Versatility for Dermatology & Aesthetic Procedures
    ADVANCED TECHNOLOGY WITH MAXIMUM VERSATILITY FOR DERMATOLOGY & AESTHETIC PROCEDURES Fractional and Non-Fractional Applications Skin Resurfacing Skin Rejuvenation Skin Tightening Scar Remodeling Skin Tags & Benign Skin Lesion Skin Imperfections “The Pixel CO2 is brilliant; it is a must - have device for all dermatologists and plastic surgeons.” Dr. Michael Shochat, MD, Dermatologist. 2 | ALMA Pixel CO2 ALMA The carbon dioxide (CO2) laser has been known to provide some of the most dramatic, age-defying results in the treatment of challenging skin imperfections including wrinkles, fine lines, photodamage, uneven skin tone and skin laxity, as well as in scar treatment, skin tags and benign tumors. Using the power of the CO2 laser, the optimal mix of ablative and thermal effects and an array of applicators and treatment modes for highly tailored procedures, Alma’s Pixel CO2 brings unparalleled precision and innovation to the field of dermatology and plastic surgery. Alma Pixel CO2 is a highly flexible system for char-free tissue ablation, vaporization, excision, incision and coagulation of soft tissue. It allows physicians full control of treatment parameters, including level and depth of ablation and thermal control via pulse duration and mode of energy delivery. This versatility maximizes precision and treatment results while minimizing unnecessary tissue damage. The CO2 laser uses a 10,600nm wavelength, which is ideal for collagen matrix renewal and an optimal choice for treating an extensive range of dermatological issues. The CO2 laser has the ability to perform efficient, highly precise fractional and non-fractional laser treatments using the widest assortment of advanced applicators. With powerful performance and hundreds of treatment options, Alma Pixel CO2 opens the door to new possibilities in dermatological and surgical treatments.
    [Show full text]
  • What Are Basal and Squamous Cell Skin Cancers?
    cancer.org | 1.800.227.2345 About Basal and Squamous Cell Skin Cancer Overview If you have been diagnosed with basal or squamous cell skin cancer or are worried about it, you likely have a lot of questions. Learning some basics is a good place to start. ● What Are Basal and Squamous Cell Skin Cancers? Research and Statistics See the latest estimates for new cases of basal and squamous cell skin cancer and deaths in the US and what research is currently being done. ● Key Statistics for Basal and Squamous Cell Skin Cancers ● What’s New in Basal and Squamous Cell Skin Cancer Research? What Are Basal and Squamous Cell Skin Cancers? Basal and squamous cell skin cancers are the most common types of skin cancer. They start in the top layer of skin (the epidermis), and are often related to sun exposure. 1 ____________________________________________________________________________________American Cancer Society cancer.org | 1.800.227.2345 Cancer starts when cells in the body begin to grow out of control. Cells in nearly any part of the body can become cancer cells. To learn more about cancer and how it starts and spreads, see What Is Cancer?1 Where do skin cancers start? Most skin cancers start in the top layer of skin, called the epidermis. There are 3 main types of cells in this layer: ● Squamous cells: These are flat cells in the upper (outer) part of the epidermis, which are constantly shed as new ones form. When these cells grow out of control, they can develop into squamous cell skin cancer (also called squamous cell carcinoma).
    [Show full text]